Introduction
============

Fungal pathogens of mammals are able to live and proliferate in a wide range of host body sites including skin surfaces and mucosa, but also internal organs. In order to successfully colonize or infect tissues offering such different conditions, pathogenic fungi need effective adaptation mechanisms. Adaptive processes are controlled by transcriptional programs and their understanding can provide critical clues in fungal pathogenesis ([@B38]; [@B40]).

Fungal transcriptomics in the host has already been addressed in different studies in several pathogens including *Cryptococcus neoformans* and *Aspergillus fumigatus* ([@B34]; [@B14]). These two fungal species are important pathogens causing high mortality in immune-compromised patients ([@B8]). These studies used microarrays and RNA sequencing (RNA-seq) approaches. In *C. neoformans*, the transcriptome in the host was performed from cerebrospinal fluid (CSF) from two AIDS patients with cryptococcal meningitis prior to antifungal therapy. The RNA was extracted from fungal cells obtained after CSF centrifugation that corresponded to 10^6^--10^8^ cells. Due to this enrichment step, the RNA extraction yielded almost only fungal material which could be further processed for direct RNA-seq analysis. The authors could analyze the profile of about 97% of all *C. neoformans* genes (from a total of about 6800 genes). Some genes were identified as significantly upregulated *in vivo* as compared to *in vitro* conditions and were genes previously recognized as contributing to pathogenicity. For example, genes with known stress response functions, such as *RIM101* (a pH-dependent regulator), *ENA1* (an ATPase transporter gene) and *CFO1* (a ferroxidase) as well as several transporters were upregulated in host samples ([@B14]). In *A. fumigatus*, the transcriptome in the host was approached using experimental nasal instillation to result in pulmonary infection in mice ([@B34]; [@B5]). *A. fumigatus* cells were recovered and enriched from bronchoalveolar lavage (BAL) samples from which RNA was directly extracted. Microarray hybridizations were carried out after amplification of *A. fumigatus* RNA. This approach allowed the resolution of 95% of the *A. fumigatus* genes (from a total of about 9000 genes; [@B34]). The *in vivo* transcriptional approaches with *A. fumigatus* allowed to perceive iron limitation, alkaline stress and nutrient adaptation as important host-dependent stresses during early stage *A. fumigatus* infection. They also revealed a biased distribution of host-response genes in subtelomeric regions of chromosomes ([@B34]; [@B5]). In a review published by [@B11], *C. neoformans* and *A. fumigatus* data were compared with each other to conclude about a high degree of convergence between the *in vivo* transcriptional data from the two pathogens. Even though the *in vivo* conditions were quite different between the two experimental systems, carbon metabolism was remarkably shifted to the glyoxylate cycle in the two fungal pathogens ([@B11]).

One of the most common fungal pathogens is *Candida albicans*, which can cause systemic infections in immunocompromised patients with mortality rates of around 50% ([@B38]; [@B40]), and it is a great example of a microorganism with remarkable adaptation capabilities. Some studies have attempted to characterize the transcriptional response of *C. albicans* during the infection process. On the opposite to *C. neoformans* and *A. fumigatus* cells which can be collected from host fluids to significant numbers, *C. albicans* sampling from the host is more problematic since *C. albicans* cells in the host are associated to host tissues or embedded in organs. This motivated *in vitro* transcriptional profile experiments in which *C. albicans* growth conditions can mimic stresses encountered by the fungus within its host (see **Table [1](#T1){ref-type="table"}** for details of significant studies). Alternatively, other studies have co-cultured *C. albicans* with mammalian cells or tissue cultures to obtain transcript profiles reflecting the adaptation of this fungal pathogen to different host cell types (see **Table [1](#T1){ref-type="table"}**). In these conditions, the recovery and enrichment of *C. albicans* cells is not technically difficult. These data may partially reflect the real gene expression landscape of *C. albicans* in the host. It is now understood that transcriptional networks can be shaped by different profiles between *in vitro* and *in vivo* experiments, thus highlighting the value of conducting such studies directly during infection ([@B23]; [@B49]). For example, there is only one commonly regulated transcription factor (*SFU1*, which is involved in iron homeostasis) between the *in vitro* and *in vivo* response to caspofungin, although 18 and 13 transcription factors genes are each upregulated by caspofungin *in vivo* and *in vitro*, respectively ([@B49]). Furthermore, the exploration of transcriptional data from *in vivo* conditions and their interpretation for biological relevance depends to some extent on the type of applied reference conditions (in most cases logarithmic growth *in vitro*; [@B11]).

###### 

Representative *in vitro* and *ex-vivo* transcriptomic analysis performed with *Candida Albicans.*

  *In vitro* condition                            *Ex vivo* condition                        Sampling time points   Expression analysis          Number of regulated genes^a^   Reference
  ----------------------------------------------- ------------------------------------------ ---------------------- ---------------------------- ------------------------------ -----------
  Shift to serum at 37°C                                                                     30 min, 6 h            Microarray (6580 ORF)        742                            [@B36]
  Heat stress, osmotic stress, oxidative stress                                              10, 30, 60 min         Microarray (6580 ORF)        972                            [@B22]
  pH shift (pH 4 vs. pH 8)                                                                   4 h                    Microarray (6175 ORF)        1084                           [@B4]
  Biofilm formation                                                                          24, 48, 72 h           Microarray (5907 ORF)        748--856                       [@B28]
  Nitric oxide exposure                                                                      10, 40, 70, 120 min    Microarray (6550 ORF)        131                            [@B31]
  Tetracycline-dependent *UME6* expression                                                   3, 10 h                Microarray (6346 ORF)        238                            [@B12]
  Low vs. high iron                                                                          5 h                    Microarray (6111 ORF)        521                            [@B13]
  Spider medium                                                                              8 h                    nanoString (293 ORF)         NA^b^                          [@B24]
                                                  Human blood                                10, 20, 30, 60 min     Membrane arrays (2002 ORF)   640                            [@B27]
                                                  Human Blood fractions (PMN, MNC, Plasma)   30 min                 Microarray (6039 ORF)        1518                           [@B26]
                                                  Human neutrophils, monocytes               60, 80 min             Microarray (6550 ORF)        246                            [@B42]
                                                  Murine macropahges                         1, 6 h                 Microarray (7600 ORF)        545                            [@B33]
                                                  Reconstituted human oral epithelium        1, 3, 6, 12, 24 h      Microarray (6039 ORF)        164 (upregulated)^c^           [@B50]
                                                  Reconstituted human oral epithelium        30 min                 Microarray (6320 ORF)        268                            [@B44]
                                                  Perfused pig liver                         12 h                   Microarray (6039 ORF)        63                             [@B45]
                                                  Human oral epithelial cells                20, 60, 180 min        Microarray (6039 ORF)        607                            [@B47]
                                                  Murine dendritic cells                     30, 60, 90, 120 min    RNA-seq                      545                            [@B46]
                                                  Human epithelial cells                     45, 90, 180 min        Microarray (6266 ORF)        44--242                        [@B39]
                                                  Human endothelial cells                    45, 90, 180 min        Microarray (6266 ORF)        54--63                         [@B39]
                                                  Human endothelial cells                    1, 5, 5, 8 h           RNA-seq                      15--31                         [@B32]
                                                  Human epithelial cell                      1, 5, 5, 8 h           RNA-seq                      21--63                         [@B32]

a

Include genes that are ≥2-fold up- and down-regulated.

b

NA, not available.

c

Only upregulated genes were available.

Even though it is technically challenging, several transcriptional studies have been performed on mice organs after systemic infection with *C. albicans* ([@B3]; [@B45]), or mice feces after GI-infection ([@B41]), as well as on biofilms grown on bloodstream-placed devices ([@B37]; see **Table [2](#T2){ref-type="table"}** for details of significant studies). The different attempts to resolve the *C. albicans* transcriptome *in vivo* have turned out to be a great challenge for researchers since fungal RNA ratios in recovered infected organs were very low as compared to host RNA. Low fungal RNA ratios in transcript profile experiments that use microarray compromise data quality due the low signal/noise ratio. Likewise, when using RNA-seq approaches, the number of fungal reads may be too low for a comprehensive coverage of the fungal ORFome.

###### 

Representative *in vivo* transcriptomic analysis performed with *C. albicans.*

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Host                      Route of infection        Time points   Organ/tissue/device   Expression analysis      Nucleic acids amplification   Number of regulated genes^a^   Reference
  ------------------------- ------------------------- ------------- --------------------- ------------------------ ----------------------------- ------------------------------ -----------
  Human                     NA^b^                     NA            Oral cavity           Microarray (6039 ORF)    No                            189 (upregulated)              [@B50]

  Neutropenic mice          IV infection^c^           6, 9, 15 h    Kidneys               Microarray (6737 ORF)    No                            652                            [@B3]

  Immuno suppressed mice    OP infection^d^           1, 5 days     Tongue                nanoString (134 ORF)     No                            65 (vs. Spider medium)         [@B23]

  Mice                      IP infection^e^           0.5, 3, 5 h   IP space              Microarray (6039 ORF)    Yes                           476                            [@B45]

  Antibiotic-treated mice   GI infection^f^           3 days        GI tract (cecum)      Microarray (6333 ORF)    No                            440                            [@B41]

  Mice                      Central venous catheter   12, 24 h      Catheter              Microarray (6737 ORF)    No                            545 (12 h)\                    [@B37]
                                                                                                                                                 1034 (24 h)                    

  Rabbit                    IV infection              3 days        Kidneys               Microarrays (6580 ORF)   No                            108                            [@B48]

  Zebra fish                IP infection              0.5--18 h     Whole fish            Microarray (6205 ORF)    No                            120 (0.5--2 h)                 [@B15]

  Mice                      IP infection              48 h          IP space              nanoString (145 ORF)     No                            NA                             [@B16]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

a

Include genes that are ≥2-fold up- and down-regulated.

b

NA, not available.

c

Intravenous infection.

d

Oro-pharyngeal infection.

e

Intra-peritoneal infection.

f

Gastro-intestinal infection.

Up to now, different strategies were developed to overcome this problem, including isolation of fungal cells prior to RNA extraction ([@B3]), or specific fungal RNA amplification post-RNA extraction ([@B45]; **Table [2](#T2){ref-type="table"}**). Enrichment of cells before RNA extraction exposed them to environmental changes before stopping transcription and RNA degradation, thus potentially modifying the observed transcriptional response ([@B3]). RNA amplification may be biased by non-linear amplification of fungal RNA because of the presence of large amounts of host RNA ([@B45]). Alternative animal models have also been used such as rabbits ([@B48]) and zebrafish ([@B15]) in order to recover higher fungal biomass and to be able to perform direct transcript profiling analyses on fungal RNA.

Most of the studies mentioned so far used microarrays to measure *C. albicans* transcriptional activity, which is a method with relatively low sensitivity in quantifying the absolute expression values and in the detection of low abundance genes ([@B21]). With more recent technologies such as RNA-seq, the detection threshold of non-aboundant transcripts has been decreased as compared to microarrays ([@B43]). RNA-seq is based on established high-throughput DNA sequencing technologies that are now mainly implemented in Illumina sequencing instruments that produce high read numbers (10^6^--10^7^ per sample). RNA-seq has been used in several genome-wide *C. albicans* transcriptional studies *in vitro* ([@B10]; [@B19]; [@B30]) or with *C. albicans*-infected mammalian cells with different resolutions (**Table [1](#T1){ref-type="table"}**; [@B46]; [@B32]). So far, only two studies have attempted the analysis of the *C. albicans* transcriptome by RNA-seq directly from host infections ([@B9]; [@B32]). These reports used either infected human samples or samples from mice systemically infected with *C. albicans*. However, these studies were confronted with the low fungal transcripts proportion in the total extracted RNA. These samples had limited sequencing depth, thus resulting in the detection of a small number of highly expressed genes only.

Novel Approaches in Fungal Transcriptome Profiling in the Host
==============================================================

Novel approaches to enable transcript profiling directly from host samples have emerged recently. The first technology, also called "nanoString" ([@B29]), consists upon two key steps (**Figure [1](#F1){ref-type="fig"}**). Briefly, two probes are specifically designed for each target gene. One probe, called the capture-probe, is linked to biotin and helps to immobilize the molecules of interest onto a counting stand. The second probe is target-specific and is called the reporter probe. This probe is made of six fluorochromes of four different colors, defining a fluorochrome code specific to each target molecule. This color code confers the technique a very high sensitivity and enables the analysis of quantity-limited biological samples. The mRNAs of selected genes can hybridize to both their corresponding capture-probe and the reporter probes, which are both in excess in the reaction liquid. The main interest of this detection method is that it is direct and does not require linear (array) or exponential (PCR) amplifications. The method provides simultaneous digital readouts of the relative abundance of the selected mRNA species within a sample. The restricted number of sample manipulation steps together with the absence of enzymatic reaction (in most cases) allows precise and physiologically correct quantifications from starting material.

![**Workflow of the nanoString strategy.** Capture probes are bound to biotin and reporter probes consist of four different fluorophores that are arranged at six different positions, thus providing a specific fluorescent signature for each probe. After mRNA hybridization and removal of excess unbound material, hybrid molecules are fixed onto a surface using electrical current which will orient all molecules. Sequential reading with a fluorescent source provides signal signatures for each specific mRNA in a quantitative manner. Adapted from [@B25].](fmicb-06-01571-g001){#F1}

The nanoString technology was adapted to *C. albicans* and allowed the fungal transcription profiling on mice samples containing less than 0,1% of *C. albicans* RNA ([@B23]). Other studies have used the nanoString technology but targeting a restricted number of *C. albicans* genes (248 out of a total of 6218 ORFs) from host samples originating from systemic and intra-peritoneal candidiasis in animal models ([@B24]; [@B16]; [@B49]). The 248 genes comprised environmentally responsive genes chosen from published genome-wide datasets. A second panel of *C. albicans* gene targets was based on the entire set of *C. albicans* transcription factors (231; [@B49]). In addition, [@B18] reported the use of nanoString for analysis of *A. fumigatus* expression from an *in vivo* murine model of invasive pulmonary aspergillosis. Here the authors used a set of 60 different probes only ([@B18]). There is no doubt that nanoString is a powerful technology with high multiplexing capability and which overcomes the problem of low fungus/host RNA ratio. Still, this technology is provided by a single supplier, it is limited to a maximal number of target genes (800) and thus cannot yield a comprehensive transcriptional profile ([@B29]).

Another technology that enables specific enrichment of a microbial transcriptome in a host is the bait capture method (SureSelect, Agilent), whose principle is outlined in **Figure [2](#F2){ref-type="fig"}**. This method was originally used to analyze the human exome ([@B6]; [@B20]; [@B35]; [@B17]) and consists of capturing the sequences of interest out of the population of total RNA molecules transcribed from the whole human genome. The hybridization is carried out in a solution containing a library of biotinylated oligonucleotides corresponding to the human exome and the sample (cDNA from total RNA). The biotylinated RNA-cDNA hybrids are next selectively captured using magnetic streptavidin beads. After extensive washing steps, the remaining cDNAs can be released after digestion of the biotinylated RNA baits and are further processed for deep sequencing. We have recently adapted this technology to *C. albicans*, by designing oligonucleotides complementary to the ORFome of this fungus ([@B2]). Using an online accessible platform (<https://earray.chem.agilent.com/earray/>), the design of biotinylated oligonucleotides can be undertaken and customized. A total of 55,342 bait probes were designed to cover 6,094 *C. albicans* ORFs. Due to cost limitations, the first 250 nucleotides of each gene were not covered in the bait design, resulting in an average of nine probes for each ORF. The use of this capture system on RNA obtained from infected host tissues resulted in enrichments in the proportion of *C. albicans* transcripts of more than 500-fold and in RNA-seq libraries containing more than 50% of fungal transcripts. To verify that neither this enrichment nor the predominating background of host material introduced a bias in the results, a simple validation was carried out. RNA from *C. albicans* was mixed with host RNA (1% of *C. albicans*, 99% of uninfected host). This spiked RNA was next subjected to enrichment with the biotinylated bait system. The results obtained from sequencing these samples were compared to those of sequencing the same *C. albicans* RNA without the presence of host RNA and without enrichment. Using this approach, we were able to verify that there was no bias for 97% of the genes. Therefore, the relative amount of each gene was the same whether the samples were subjected to the enrichment procedures or not. Moreover, a machine learning approach helped to delimitate the necessary features for the baits in order to efficiently capture their target genes. Such information will be useful for future designs of bait libraries, either targeting *C. albicans* or other organisms.

![**Workflow of the mRNA enrichment strategy using the SureSelect technology.** The technology consists of capturing the mRNAs of interest out of the population of total RNA molecules transcribed from mixed genomes. A library of biotinylated oligonucleotides (corresponding to an ORFome and consisting of overlapping oligonucleotides for each gene) is hybridized in a solution with a sample (cDNA from total RNA). Biotylinated RNA-cDNA hybrids can be selectively captured with magnetic streptavidin-coated beads. After digestion of the biotinylated RNA baits, the remaining cDNA can be sequenced by high throughput sequencing approaches (RNA-seq).](fmicb-06-01571-g002){#F2}

This enrichment method allowed RNA-sequencing of *C. albicans* from infected mouse kidneys, after 16 and 48 h of infection, and from infected *Galleria mellonella* larvae, 2 and 24 h post-infection. These samples revealed a high resolution transcriptome, showing the expression levels of over 80% of all *C. albicans* genes, constituting a huge improvement in resolution relatively to previous *in vivo* transcriptional analyses of this microorganism. Over 1000 genes were found to be statistically up- or down-regulated *in vivo* relatively to *in vitro* when performing a meta-analysis that identified genes commonly regulated in the four different conditions. Several functions were enriched among these genes, including some typically associated with virulence, such as adhesion, iron homeostasis, stress response, response to starvation, and biofilm formation. On the other hand, such detailed landscape of the *C. albicans* gene expression profile allowed the identification of a large number of genes that were so far ignored to participate in the process of host invasion and infection, and these alone will be targets of investigation for years to come.

The two models of infection, mouse and insect larvae, elicited surprisingly similar transcriptional responses from *C. albicans*, highlighting the adequation of this insect model to study *C. albicans* virulence. These data are consistent with studies that revealed a good correlation between *C. albicans* virulence in mice invasive models and the insect larvae ([@B7]; [@B1]). Unfortunately, the libraries enriched for *C. albicans* cannot be used to analyze the host transcriptome without a non-negligible bias. Still, dual RNA-seq of host and pathogen can be performed on the same RNA sample, if both a non-enriched and an enriched library are prepared and sequenced.

Taking datasets produced from both technologies analyzing *C. albicans* systemic infection in mice, we compared sets of *C. albicans* genes that were common between both studies and estimated the expression levels as compared to *in vitro* grown cells. We considered only early infection times of both studies for the comparison and only genes that were significantly regulated as compared to *in vitro* conditions. With a set of 56 genes in common between both studies, the data showed a high correlation (*R*^2^: 0.8) between observed gene expression levels (**Figure [3](#F3){ref-type="fig"}**). This high correlation in gene expression profile is remarkable, given the different experimental conditions between both studies (choice of time points, choice of mice strain) and the different analytical approaches taken. Among the genes that were commonly upregulated in both data sets, genes relevant for *C. albicans* pathogenesis can be identified including: (i) *HWP1* (hyphal specific protein involved in adhesion to epithelial cells) and *ALS3* (adhesin involved in the adherence of *C. albicans* to endo- and epithelial cells), (ii) *ZRT1* and *PRA1* (zinc transporter and zinc binding protein important for zinc acquisition of *C. albicans*) and (iii) *FTR1* (a high-affinity iron permease) and *SIT1* (a transporter of ferrichrome siderophores). These results suggest that the enrichment/RNA-seq method can be an alternative to nanoString when whole genome data are required.

![**Correlations between log2 fold change data generated by nanoString and enrichment/RNA-seq approaches ([@B2]; [@B49]), taking early gene expression patterns from both studies (nanoString: mouse kidneys 12 h post infection versus *in vitro* stationary-phase culture; enrichment/RNA-seq: mouse kidneys 16 h post infection versus *in vitro* exponential-phase culture).** The total number of genes regulated at early time points in [@B49] and [@B2] was 148 and 1114, respectively. *R*^2^: *R* squared Pearson correlation coefficient, calculated with Prism 6.0.](fmicb-06-01571-g003){#F3}

Conclusion and Perspectives
===========================

The two novel transcriptional approaches, nanoString and RNA-seq following enrichment, represent powerful tools to analyze the behavior of pathogens during infection. With RNA samples directly taken from within its host, the technical challenges of quantification of fungal mRNA in a complex host mixture have now been overcome, with the difference that nanoString targets still a limited number of genes of interest while enrichment/RNA-seq is genome-wide. Future applications of enrichment/RNA-seq may include the transcriptome analysis of *C. albicans* mutants with reduced virulence. So far, this task was even more challenging than for wild-type strains due to the reduced fungal burdens often found for such mutants in host organs, thus further reducing the proportion of fungal versus host biomass. With the potential of these transcriptome technologies, it will be also possible to investigate *C. albicans* gene expression in other contexts, such as from different organs during systemic infection or during other types of infections, like oropharyngeal candidiasis, mucosal infections or gastrointestinal colonization. Importantly, since these methods allow the selective sequencing of fungal transcripts, it will be now possible to perform such studies directly on human biopsies from solid tissues, even if containing low amounts of fungal cells. Such data will be useful to estimate to which extent the *C. albicans* transcriptome from clinical samples differs from animal models. Moreover, the possible applications of transcriptome technologies are obviously not limited to *C. albicans*. To apply them to other pathogens, one needs simply to design a set of probes matching the ORFome of the organism of interest. Both approaches currently implicate significant costs given their technical specificities and the need to perform experiments in duplicates or triplicates (for example about 600 USD per sample for analysis of 500 genes by nanoString; about 500 USD for SureSelect application and RNA-seq per sample for whole *C. albicans* genome). The significant costs of these technologies are originating from capture probe biosynthesis, which might be reduced in the future by novel chemistry. On the other hand, the expansion of their future use will probably contribute to decrease their price.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

This work was supported by Swiss National Science Foundation grant CRSII3_141848 (Sinergia) to DS.

[^1]: Edited by: *Gustavo Henrique Goldman, Universidade de Sao Paulo, Brazil*

[^2]: Reviewed by: *Attila Gacser, University of Szeged, Hungary; Sven Krappmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen, Germany*

[^3]: This article was submitted to Fungi and Their Interactions, a section of the journal Frontiers in Microbiology
